St Jude to acquire CardioMEMS after heart failure monitor clears US FDA hurdle
This article was originally published in Clinica
Executive Summary
The US FDA approval of CardioMEMS’s HF wireless heart-failure monitor has enticed the company’s investor St Jude Medical to go all out and buy the technology and its manufacturer.